CURRENT AFFAIRS

Detailed explanation-1: -As reported, analysts were told by Johnson & Johnson executives that the separation, which will result in the creation of a new publicly-traded company for consumer health, will allow each division to be more nimble in adjusting to their individual markets.

Detailed explanation-2: -Planned New Consumer Health Company. NEW BRUNSWICK, N.J. September 28, 2022 - Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company.

Detailed explanation-3: -At Johnson & Johnson, the focus is on managing for the long term-building the long-term equity of our brands, building sustainable customer loyalty and building shareholder value over time. As a result, 70% of the sales are from products in global market share.

Detailed explanation-4: -What happens to JNJ stock when the company splits? Once Johnson and Johnson splits, JNJ stock will only give traders and investors exposure to the medical device and pharmaceutical proceeds of the company. The new company, which will be listed as Kenvue, will trade separately.